Clinical trial Recruiting at 1 site Interventional Ages 45 to 50

Biofeedback-Assisted Pelvic Floor Training After Hysterectomy

Official title: Effectiveness of Biofeedback-Assisted Pelvic Floor Muscle Training on Sexual Function and Quality of Life in Patient After Hysterectomy

Run by Kafrelsheikh University · NCT07784465 · Data updated 2026-11-12

This study tests whether biofeedback-guided pelvic floor exercises after hysterectomy can improve pelvic floor strength, reduce urinary leakage, lessen genital prolapse, and boost quality of life.

Quick facts

Study typeInterventional
Ages45 Years to 50 Years
SexAll
Enrollment70 (estimated)
SponsorKafrelsheikh University
Academic / other
Locations1 site (Kafr ash Shaykh, Kafrelsheikh)
StatusRecruiting
StartedJanuary 1, 2026
Main results expectedOctober 1, 2026
Study endsOctober 1, 2026
Registry record updatedAugust 25, 2026
Trial IDNCT07784465 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 45-50 who recently had an abdominal hysterectomy for benign conditions and have signs of pelvic floor dysfunction.

Probably not a fit

Women without pelvic floor dysfunction symptoms or those unable to adhere to the training may not experience benefits.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study investigates the effectiveness of adding biofeedback to standard postoperative pelvic floor rehabilitation for women who have undergone hysterectomy for benign conditions. Participants will perform pelvic floor muscle training with biofeedback alongside routine post-surgical care. The trial aims to measure changes in pelvic floor strength, urinary incontinence symptoms, genital prolapse, and overall quality of life. Eligible participants are women aged 45-50 who recently had an abdominal hysterectomy and have pelvic floor dysfunction symptoms. Exclusion criteria include hysterectomy for malignancy, prior pelvic floor rehab, neurological disorders affecting muscle control, infection, or inability to follow the program.

Why it matters

Potential benefit: If successful, participants may experience stronger pelvic floor muscles, less urinary leakage, reduced prolapse symptoms, and improved daily living quality.

How similar studies have gone: Previous pelvic floor training studies suggest potential benefits, and biofeedback has shown promise in enhancing PFMT adherence and outcomes in related populations.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Women aged 45-50 years.
* Body Mass Index (BMI) within the range of 18.5 to 29.9 kg/m².
* History of total or subtotal hysterectomy for benign conditions within the past 6 months.
* Abdominal hysterectomy.
* Women have menstrual cycle.
* Presenting with at least one symptom of pelvic floor dysfunction (e.g., stress urinary incontinence and genital prolapse).
* Willing to participate and provide informed consent.

Exclusion Criteria:

* Hysterectomy performed for malignant conditions.
* Prior pelvic floor rehabilitation.
* Neurological disorders affecting muscle control.
* Pelvic infection or current urinary tract infection (UTI).
* Inability to follow instructions or adhere to the program.

Where it's running

  • Kafrelsheikh University (Faculty of Physical Therapy)
    Kafr ash Shaykh, Kafrelsheikh, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.